Buspirone Hydrochloride Tablet
Product Images NDC 71610-206
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)
This is a table that shows the different dosages of a medication in milligrams (mg). The medication is available in 15 mg and 30 mg tablets, and the table displays the different amounts of the tablets that should be taken based on the prescribed dosage. For example, if the doctor prescribed a 15 mg dosage, the patient can take the full tablet (15 mg), two-thirds of the tablet (10 mg), one-third of the tablet (5 mg), or half of the tablet (7.5 mg). If the doctor prescribed a 30 mg dosage, the patient can take the full tablet (30 mg), two-thirds of the tablet (20 mg), one-third of the tablet (10 mg), or half of the tablet (15 mg).*
Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 03)
Bottle Label 15 mg (71610 0206 30)
Aphena Pharma Solutions (TN)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.